CIK 0001811063 · Pharmaceutical Preparations (SIC 2834) · NYSE · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 62.9 M | |||
| Net income (USD) | -104.2 M | -86.8 M | ||
| Diluted EPS (USD/shares) | -0.6 | -0.35 | -0.48 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-08-21 | 4 | 4 | 2026-08-19 |
| 2026-08-19 | 144 | 144 | |
| 2026-08-06 | 8-K | 8-K items 2.02,9.01 | 2026-08-06 |
| 2026-08-06 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-17 | 4 | 4 | 2026-07-15 |
| 2026-07-06 | 8-K | 8-K items 2.03,8.01,9.01 | 2026-06-30 |
| 2026-06-30 | 8-K | 8-K items 1.01,1.02,2.03,8.01,9.01 | 2026-06-24 |
| 2026-06-29 | 424B5 | 424B5 | |
| 2026-06-29 | 305B2 | 305B2 | |
| 2026-06-26 | FWP | FWP | |
| 2026-06-25 | 424B5 | 424B5 | |
| 2026-06-24 | 4 | 4 | 2026-06-23 |
| 2026-06-24 | 4 | 4 | 2026-06-23 |
| 2026-06-24 | 4 | 4 | 2026-06-23 |
| 2026-06-23 | 144 | 144 | |
| 2026-06-23 | 144 | 144 | |
| 2026-06-23 | 144 | 144 | |
| 2026-06-11 | 4 | 4 | 2026-06-09 |
| 2026-05-27 | 8-K | 8-K items 5.07 | 2026-05-21 |
| 2026-05-26 | 4 | 4 | 2026-05-21 |
| 2026-05-26 | 4 | 4 | 2026-05-21 |
| 2026-05-26 | 4 | 4 | 2026-05-21 |
| 2026-05-26 | 4 | 4 | 2026-05-21 |
| 2026-05-26 | 4 | 4 | 2026-05-21 |
| 2026-05-26 | 4 | 4 | 2026-05-21 |
Forms on file (last 1,000): 4 146, 8-K 59, 3 31, 10-Q 19, 144 17, SC 13G/A 9, 424B3 9, SC 13G 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=NUVB (0.002 USD), /gw/filings/filings?ticker=NUVB&form=8-K, /gw/filings/facts?ticker=NUVB&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange